Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

Northwestern Medicine scientists have uncovered new details about how poxvirus hijacks its host's protein synthesis machinery ...

Global mRNA Cancer Vaccines Clinical Trials, Market Trends By Indication, Development Priority Status and Market Opportunity ...

TriLink BioTechnologies & Quantoom Biosciences ink license and supply pact for CleanCap mRNA capping technology: San Diego Wednesday, June 4, 2025, 16:00 Hrs [IST] TriLink BioTech ...

A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...

Scientists at Cornell University have created a new material that could improve how mRNA vaccines work by making them safer ...

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

MS patients on B-cell depleting therapies are still protected against COVID-19 risk due to greater anti-viral T-cell activity, a study found.

MIAMI, FL / ACCESS Newswire / May 29, 2025 / Ludwig Enterprises (LUDG) today announced the publication of an abstract on the American Society of Clinical Oncology (ASCO) website in connection with the ...